ProbioBrain™ wins NutraIngredients second award, reinforcing global leadership in mental wellness
Novonesis’ ProbioBrain™, powered by the unique Bifidobacterium longum 1714™ psychobiotic strain, has been awarded the NutraIngredients Awards Asia in the Mood and Mind category.
COPENHAGEN, Denmark – September 26, 2025. The achievement follows Novonesis’ earlier recognition at the NutraIngredients Awards Europe, marking a dual win and establishing ProbioBrain™ as a global benchmark for science-backed mental wellness solutions.
"Winning a second NutraIngredients Awards validates our conviction that psychobiotics represent the future of mental wellness and recognizes Novonesis as a standout reference point in psychobiotic research. This second recognition demonstrates that science-backed solutions addressing the gut-brain axis aren't just innovative – they're essential for meeting consumers' evolving wellness needs and helping our partners differentiate in this rapidly expanding market.”
says Jakob Dalmose Rasmussen, Vice President, Novonesis Human Health Biosolutions.
A unique strain with multiple benefits
ProbioBrain™, with the unique Bifidobacterium longum 1714™ psychiobiotic strain, is a breakthrough in psychobiotic research. Not only does ProbioBrain™ naturally produce tryptophan and help significantly reduce cortisol levels - it also features a unique outer layer that supports immune system regulation and protects the brain from harmful processes.
As Louis Koeninger, Global Scientific Advisor at Novonesis, explains: “ProbioBrain™ is transforming the mental wellness landscape. It is a daily companion targeting stress resilience, sleep quality, energy and vitality, calmness, and emotional balance through clinically backed science on the gut-brain axis1.”
Belonging to a novel class of probiotics, Bifidobacterium longum 1714™ naturally thrives in the human gut and, when consumed in adequate amounts, has been clinically shown to deliver positive mental health benefits. Its proven efficacy exemplifies Novonesis’ aim: to pioneer biosolutions that enable better health and enrich lives on a global scale.
Not all psychobiotics are created equal
“Certain psychobiotics have been shown to increase tryptophan levels, which are actively transported across the blood–brain barrier. Tryptophan is a well-established building block of serotonin, a key regulator of mood and sleep. Some psychobiotic strains can also help reduce cortisol levels,”
says Professor Ted Dinan, Emeritus Professor of Psychiatry, University College Cork.
Over the years, Professor Ted Dinan, and Professor John F. Cryan, Chair of Anatomy and Neuroscience at University College Cork, have worked with different probiotic bacteria, most of which do not elevate tryptophan levels.
Meeting the evolving needs of consumers
As the mental wellness sector expands rapidly, consumers increasingly seek solutions that target specific pain points, such as everyday stress, feelings of anxiousness, staying calm, enhancing sleep quality and feeling rested.2
The consecutive awards reinforce ProbioBrain™ as a reference in psychobiotic innovation and highlight Novonesis’ dedication to advancing microbiome science through research, partnerships, and an unwavering commitment to meet evolving wellness needs.
- Information is based on internal data and unpublished data.
- Euromonitor. Consumers trends (2023)
About Novonesis
Novonesis is leading the era of biosolutions. By leveraging the power of microbiology with science, we transform the way the world produces, consumes and lives. In more than 30 industries around the world, our biosolutions are already creating value for thousands of customers and benefiting the planet. Our 10,000 people worldwide work closely with our partners and customers to transform business with biology.
Let’s better our world with biology.
Get in touch
Media relations
